OVERVIEW

Association for Accessible Medicines (AAM) Access! 2021 virtual Annual Meeting is organized by Association for Accessible Medicines (AAM) and will be held from May 26 - 27, 2021.

Who is Access! 2021 for?
C-Suite Executives
Generics and biosimilars industry executives convene to understand the forces impacting their industry and shape the future of their business.

Policy professionals/industry professionals/regulators
Take this opportunity to interact with others in the industry and gain a fuller understanding of how regulations affect the real world. In addition, connect with global influencers, increase your knowledge base to stay on the cutting edge and learn about best practices to enhance your organization’s overall performance.

Legal professionals
Get current information on the latest legal issues affecting the approval of and access to generic drugs and biosimilars.

Business Development
Discover how Access! 2021 can work for you on a national or global scale. New and renewed alliances, partnerships, investments and strategic relationships of all kinds can be sparked or strengthened here.

Description:
AAM's annual meeting Access!™ 2021 brings together policymakers, influential speakers and industry leaders to chart the future of generics and biosimilars. Discussions center around the business, breakthroughs and politics that shape our industry. It’s the opportunity to hear firsthand from world-renowned speakers and learn about where our industry is heading and what our future holds.

Access! 2021 is a fully interactive conference with the ability to chat with other conference attendees, speakers and exhibitors. You will also be able to download conference materials to review later.

• Access to the latest information about generics + biosimilars
• Insights into the future of our industry
• Interaction with leaders in the industry
• Opportunities to network with industry peers

Why You Should Attend Access! 2021:
• Increased program access to accommodate a 24-hour global time zone
• Presentations by top industry professionals
• The chance to connect with exhibitors at our virtual expo
• A variety of panels on issues vital to the generic and biosimilar medicines industry
• Live and on-demand sessions
• Networking tools to connect with industry peers

Additional details will be posted as soon as information is available.